To the Editor Alore et al1 reported that veterans were underdiagnosed and undertreated for primary hyperparathyroidism (pHPT). This is a nice study, and the authors are to be commended for addressing an interesting issue. However, there are several caveats that need to be addressed prior to making definitive conclusions on the management of pHPT. We look forward to the authors comments on the following:
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Gaschen P, Almekdash MH, Peiris A. Diagnosis and Management of Hyperparathyroidism. JAMA Intern Med. 2019;179(12):1732. doi:10.1001/jamainternmed.2019.5129
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: